Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:54:25.540Z.
Calculation as of: 2026-10-06T19:54:25.540Z.
Quote observation: 2026-10-06T19:50:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dc4657557541446f84d9f7820ae4f915e84790dbce56ed6e08d87a0074ca8553
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Viking Therapeutics, Inc.
Market Cap
$3.31B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.37B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.38B
Free Cash Flow Yield
5.16%
TTM Avg
3.81%
3Y Avg
3.52%
5Y Avg
3.52%
Market Cap
$3.43B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.19B
Free Cash Flow Yield
1.93%
TTM Avg
1.89%
3Y Avg
1.89%
5Y Avg
1.35%
Market Cap
$3.46B
Free Cash Flow Yield
N/A
TTM Avg
9.07%
3Y Avg
9.10%
5Y Avg
9.10%
Market Cap
$3.52B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | $3.31B | N/A | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.32B | 2.56% | 3.72% | 2.68% | 2.68% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.37B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 5.16% | 3.81% | 3.52% | 3.52% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.43B | N/A | N/A | N/A | N/A |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | 1.93% | 1.89% | 1.89% | 1.35% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.46B | N/A | 9.07% | 9.10% | 9.10% |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.52B | N/A | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.10B | N/A | 9.18% | 9.18% | 9.18% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
